AK117

AK117 · Akesobio Australia Pty Ltd

Drug timelines are a Plus or Pro feature.

14 regulatory and trial events tracked for AK117, covering 2022-08-11 to 2026-03-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study of AK117/AK112 in Metastatic Triple-Negative Breast Cancer [Phase 2]